Hans Jørgen Nielsen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Frederiksen C; Lomholt A F; Davis G J; Dowell B L; Blankenstein M A; Christensen I J; Brünner N; Nielsen H J
Changes in plasma TIMP-1 levels after resection for primary colorectal cancer.
Burgdorf Stefan K; Claesson Mogens H; Nielsen Hans J; Rosenberg Jacob
Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination.
Johansen Julia S; Lottenburger Tine; Nielsen Hans Jørgen; Jensen Jens Erik B; Svendsen Mads N; Kollerup Gine; Christensen Ib J
Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hans Jørgen Nielsen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Frederiksen C; Lomholt A F; Davis G J; Dowell B L; Blankenstein M A; Christensen I J; Brünner N; Nielsen H J
Changes in plasma TIMP-1 levels after resection for primary colorectal cancer.
Anticancer research 2009;29(1):75-81.
2009: Burgdorf Stefan K; Claesson Mogens H; Nielsen Hans J; Rosenberg Jacob
Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination.
Acta oncologica (Stockholm, Sweden) 2009;48(8):1157-64.
2008: Johansen Julia S; Lottenburger Tine; Nielsen Hans Jørgen; Jensen Jens Erik B; Svendsen Mads N; Kollerup Gine; Christensen Ib J
Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(10):2603-8.
2008: Schrohl Anne-Sofie; Würtz Sidse; Kohn Elise; Banks Rosamonde E; Nielsen Hans Jørgen; Sweep Fred C G J; Brünner Nils
Banking of biological fluids for studies of disease-associated protein biomarkers.
Molecular & cellular proteomics : MCP 2008;7(10):2061-6.
2008: Ytting Henriette; Christensen Ib Jarle; Thiel Steffen; Jensenius Jens Christian; Nielsen Hans Jørgen
Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 -a prognostic marker in colorectal cancer.
Human immunology 2008;69(7):414-20.
2008: Jørgensen Julie; Ytting Henriette; Steffensen Rudi M; Nielsen Hans Jørgen
[Mannan-binding lectin and MBL-associated serine protease-2]
Ugeskrift for laeger 2008;170(17):1445-8.
2008: Frederiksen C B; Lomholt A F; Lottenburger T; Davis G J; Dowell B L; Blankenstein M A; Christensen I J; Brunner N; Nielsen H J
Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1.
The International journal of biological markers 2008;23(1):42-7.
2008: Holten-Andersen L; Jensen S Beier; Bardow A; Harslund J; Thaysen-Andersen M; Lademann U; Usher P Autzen; Offenberg H; Højrup P; Reibel J; Nielsen H J; Brünner N; Nauntofte B
Identifying sources and estimating glandular output of salivary TIMP-1.
Scandinavian journal of clinical and laboratory investigation 2008;68(7):548-54.
2008: Nielsen Hans Jørgen; Brünner Nils; Frederiksen Camilla; Lomholt Anne Fog; King Denis; Jørgensen Lars Nannestad; Olsen Jesper; Rahr Hans B; Thygesen Knud; Hoyer Ute; Laurberg Søren; Christensen Ib Jarle;
Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection.
Scandinavian journal of gastroenterology 2008;43(2):242-8.
2008: Sørensen Nanna Møller; Schrohl Anne Sofie; Jensen Vibeke; Christensen Ib Jarle; Nielsen Hans Jørgen; Brünner Nils
Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
Scandinavian journal of gastroenterology 2008;43(2):186-91.
2007: Ytting H; Christensen I J; Thiel S; Jensenius J C; Svendsen M N; Nielsen L; Lottenburger T; Nielsen H J
Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise.
Scandinavian journal of immunology 2007;66(4):458-64.
2007: Usher P A; Sieuwerts A M; Bartels A; Lademann U; Nielsen H J; Holten-Andersen L; Foekens J A; Brünner N; Offenberg H
Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue.
Molecular oncology 2007;1(2):205-15.
2007: Sørensen Nanna M; Byström Per; Christensen Ib J; Berglund Ake; Nielsen Hans Jørgen; Brünner Nils; Glimelius Bengt
TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4117-22.
2007: Caspersen M B; Sørensen N M; Schrohl A S; Iversen P; Nielsen H J; Brünner N
Investigation of tissue inhibitor of metalloproteinases 1 in plasma from colorectal cancer patients and blood donors by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
The International journal of biological markers 2007;22(2):89-94.
2007: Sennels H P; Jacobsen S; Jensen T; Hansen M S; Ostergaard M; Nielsen H J; Sørensen S
Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein.
Scandinavian journal of clinical and laboratory investigation 2007;67(8):821-35.
2007: Frederiksen C; Lykke J; Christensen Ib J; Brünner N; Nielsen H J
Tissue inhibitor of metalloproteinase-1 levels in plasma from tumour arteries and veins of patients with rectal cancer.
Scandinavian journal of clinical and laboratory investigation 2007;67(5):545-52.
2006: Svendsen Mads N; Ytting Henriette; Brünner Nils; Nielsen Hans J; Christensen Ib J
Preoperative concentrations of suPAR and MBL proteins are associated with the development of pneumonia after elective surgery for colorectal cancer.
Surgical infections 2006;7(5):463-71.
2006: Holten-Andersen Mads Nikolaj; Nielsen Hans Jørgen; Sørensen Steen; Jensen Vibeke; Brünner Nils; Christensen Ib Jarle
Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2006;42(12):1889-96.
2006: Ytting H; Christensen I J; Basse L; Lykke J; Thiel S; Jensenius J C; Nielsen H J
Influence of major surgery on the mannan-binding lectin pathway of innate immunity.
Clinical and experimental immunology 2006;144(2):239-46.
2006: Holten-Andersen M N; Brünner N; Nielsen H J; Christensen I J; Sørensen N Møller; Rasmussen A S Schrohl; Primdahl H; Orntoft T
Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer.
The International journal of biological markers 2006;21(1):6-11.
2005: Svendsen M N; Werther K; Christensen I J; Basse L; Nielsen H J
Influence of open versus laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its soluble receptor 1 (sVEGFR1).
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2005;54(11):458-63.
2005: Nielsen Hans Jørgen; Christensen Ib Jarle; Brünner Nils Age
[Serological markers of colorectal cancer]
Ugeskrift for laeger 2005;167(44):4163-7.
2005: Larsen M B; Stephens R W; Brünner N; Nielsen H J; Engelholm L H; Christensen I J; Stetler-Stevenson W G; Høyer-Hansen G
Quantification of tissue inhibitor of metalloproteinases 2 in plasma from healthy donors and cancer patients.
Scandinavian journal of immunology 2005;61(5):449-60.
2005: Riisbro R; Christensen I J; Nielsen H J; Brünner N; Nilbert M; Fernebro E
Preoperative plasma soluble urokinase plasminogen activator receptor as a prognostic marker in rectal cancer patients. An EORTC-Receptor and Biomarker Group collaboration.
The International journal of biological markers 2005;20(2):93-102.
2005: Ytting Henriette; Christensen Ib Jarle; Jensenius Jens Christian; Thiel Steffen; Nielsen Hans Jørgen
Preoperative mannan-binding lectin pathway and prognosis in colorectal cancer.
Cancer immunology, immunotherapy : CII 2005;54(3):265-72.
2005: Ytting Henriette; Christensen Ib Jarle; Thiel Steffen; Jensenius Jens Christian; Nielsen Hans Jørgen
Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: relation to recurrence and mortality.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(4):1441-6.
2005: Bülow Steffen; Christensen Ib Jarle; Harling Henrik; Kronborg Ole; Fenger Claus; Nielsen Hans Jørgen;
[Local recurrence and survival after mesorectal excision for rectal cancer--secondary publication]
Ugeskrift for laeger 2005;167(4):401-3.
2005: Holten-Andersen Mads N; Hansen Ulla; Brünner Nils; Nielsen Hans Jørgen; Illemann Martin; Nielsen Boye Schnack
Localization of tissue inhibitor of metalloproteinases 1 (TIMP-1) in human colorectal adenoma and adenocarcinoma.
International journal of cancer. Journal international du cancer 2005;113(2):198-206.
2005: Svendsen M N; Lykke J; Werther K; Bisgaard T; Christensen I J; Nielsen H J
Bacterial antigen induced release of soluble vascular endothelial growth factor (VEGF) and VEGFR1 before and after surgery.
Scandinavian journal of clinical and laboratory investigation 2005;65(3):237-47.
2004: Lykke Jakob; Nielsen Hans Jørgen
Haemostatic alterations in colorectal cancer: perspectives for future treatment.
Journal of surgical oncology 2004;88(4):269-75.
2004: Mynster T; Nielsen H J; Harling H; Bülow S;
Blood loss and transfusion after total mesorectal excision and conventional rectal cancer surgery.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2004;6(6):452-7.
2004: Holten-Andersen Mads N; Fenger Claus; Nielsen Hans Jørgen; Rasmussen Anne-Sofie Schrohl; Christensen Ib Jarle; Brünner Nils; Kronborg Ole
Plasma TIMP-1 in patients with colorectal adenomas: a prospective study.
European journal of cancer (Oxford, England : 1990) 2004;40(14):2159-64.
2004: Lykke Jakob; Nielsen Hans Jørgen
[Hypercoagulation and cancer. New treatment possibilities]
Ugeskrift for laeger 2004;166(33):2781-4.
2004: Illemann Martin; Hansen Ulla; Nielsen Hans Jørgen; Andreasen Peter A; Høyer-Hansen Gunilla; Lund Leif R; Danø Keld; Nielsen Boye Schnack
Leading-edge myofibroblasts in human colon cancer express plasminogen activator inhibitor-1.
American journal of clinical pathology 2004;122(2):256-65.
2004: Riisbro R; Brünner N; Christensen I J; Nielsen H J
Soluble urokinase plasminogen activator receptor in blood transfusion components.
Transfusion medicine (Oxford, England) 2004;14(4):305-12.
2004: Ytting H; Jensenius J C; Christensen I J; Thiel S; Nielsen H J
Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer.
Scandinavian journal of gastroenterology 2004;39(7):674-9.
2004: Holten-Andersen M; Christensen I J; Nilbert M; Bendahl P O; Nielsen H J; Brünner N; Fernebro E;
Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival. a validation study.
European journal of cancer (Oxford, England : 1990) 2004;40(1):64-72.
2004: Svendsen Mads N; Lykke Jakob; Werther Kim; Christensen Ib J; Nielsen Hans J
Concentrations of VEGF and VEGFR1 in paired tumor arteries and veins in patients with rectal cancer.
Oncology research 2004;14(11-12):611-5.
2003: Petersen Tina Marie; Larsen Torben; Nielsen Hans Jørgen
[Angiogenic proteins: possible markers of physiopathological processes during fetal development]
Ugeskrift for laeger 2003;165(32):3082-7.
2003: Bülow S; Christensen I J; Harling H; Kronborg O; Fenger C; Nielsen H J;
Recurrence and survival after mesorectal excision for rectal cancer.
The British journal of surgery 2003;90(8):974-80.
2003: Holten-Andersen M N; Schrohl A S; Brünner N; Nielsen H J; Høgdall C K; Høgdall E V S
Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay.
The International journal of biological markers 2003;18(3):170-6.
2003: Lykke J; Nielsen H J
The role of tissue factor in colorectal cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003;29(5):417-22.
2003: Lykke Jakob; Rasmussen Hans Morten Schnack; Nielsen Hans Jørgen
[Heparin as adjuvant in the treatment of colorectal cancer?]
Ugeskrift for laeger 2003;165(18):1866-7.
2003: Werther Kim; Sørensen Sten; Christensen Ib J; Nielsen Hans J;
Circulating vascular endothelial growth factor six months after primary surgery as a prognostic marker in patients with colorectal cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(8):837-45.
2002: Nielsen H J; Christensen I J; Svendsen M N; Hansen U; Werther K; Brünner N; Petersen L J; Kristensen J K
Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2002;51(11):563-7.
2002: Nielsen H J; Christensen I J; Moesgaard F; Kehlet H;
Ranitidine as adjuvant treatment in colorectal cancer.
The British journal of surgery 2002;89(11):1416-22.
2002: Werther Kim; Bülow Steffen; Hesselfeldt Peter; Jespersen Nils Frode Kragh; Svendsen Mads Nordahl; Nielsen Hans Jørgen
VEGF concentrations in tumour arteries and veins from patients with rectal cancer.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2002;110(9):646-50.
2002: Høgdall Claus K; Christensen Ib J; Stephens Ross W; Sørensen Steen; Nørgaard-Pedersen Bent; Nielsen Hans J
Serum tetranectin is an independent prognostic marker in colorectal cancer and weakly correlated with plasma suPAR, plasma PAI-1 and serum CEA.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2002;110(9):630-8.
2002: Holten-Andersen Mads N; Christensen Ib Jarle; Nielsen Hans Jørgen; Lilja Hans; Murphy Gillian; Jensen Vibeke; Brünner Nils; Piironen Timo
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay.
Clinical chemistry 2002;48(8):1305-13.
2002: Cintin Christina; Johansen Julia S; Christensen Ib Jarle; Price Paul A; Sørensen Steen; Nielsen Hans Jørgen
High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.
Cancer 2002;95(2):267-74.
2002: Svendsen Mads Nordahl; Werther Kim; Nielsen Hans Jørgen; Kristjansen Paul E G
VEGF and tumour angiogenesis. Impact of surgery, wound healing, inflammation and blood transfusion.
Scandinavian journal of gastroenterology 2002;37(4):373-9.
2002: Werther K; Christensen I J; Nielsen H J;
Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma.
British journal of cancer 2002;86(3):417-23.
2002: Holten-Andersen Mads N; Christensen Ib Jarle; Nielsen Hans Jørgen; Stephens Ross W; Jensen Vibeke; Nielsen Ole Haagen; Sørensen Steen; Overgaard Jens; Lilja Hans; Harris Adrian; Murphy Gillian; Brünner Nils
Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(1):156-64.
2002: Hammer Janne H; Mynster Tommie; Rosendahl Solveig; Reimert Claus M; Brünner Nils; Skov Flemming; Nielsen Hans J
Bacterial antigen-induced release of white cell- and platelet-derived bioactive substances in vitro.
International journal of gastrointestinal cancer 2002;31(1-3):165-79.
2002: Werther K; Christensen I J; Nielsen H J
Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets.
Scandinavian journal of clinical and laboratory investigation 2002;62(5):343-50.
2002: Holten-Andersen M N; Brunner N; Christensen I J; Jensen V; Nielsen H J
Levels of tissue inhibitor of metalloproteinases-1 in blood transfusion components.
Scandinavian journal of clinical and laboratory investigation 2002;62(3):223-30.
2002: Werther K; Normark M; Brünner N; Nielsen H J
Cytokeratin-positive cells in preoperative peripheral blood and bone marrow aspirates of patients with colorectal cancer.
Scandinavian journal of clinical and laboratory investigation 2002;62(1):49-57.
2001: Riisbro R; Stephens R W; Brünner N; Christensen I J; Nielsen H J; Heilmann L; von Tempelhoff G F
Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Gynecologic oncology 2001;82(3):523-31.
2001: Mynster T; Nielsen H J;
Storage time of transfused blood and disease recurrence after colorectal cancer surgery.
Diseases of the colon and rectum 2001;44(7):955-64.
2001: Edvardsen L; Taaning E; Dreier B; Christensen L D; Mynster T; Nielsen H J
Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
American journal of hematology 2001;67(3):157-62.
2001: Nielsen H J; Werther K; Mynster T; Svendsen M N; Rosendahl S; Elley T; Skov F
Bacteria-induced release of white cell--and platelet-derived vascular endothelial growth factor in vitro.
Vox sanguinis 2001;80(3):170-8.
2001: Werther K; Christensen I J; Nielsen H J;
The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer.
The European journal of surgery = Acta chirurgica 2001;167(4):287-92.
2001: Nielsen H J; Mortensen T; Holten-Andersen M; Brünner N; Sørensen S; Rask-Madsen J
Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease.
Scandinavian journal of gastroenterology 2001;36(3):265-9.
2001: Cintin C; Johansen J S; Skov F; Price P A; Nielsen H J
Accumulation of the neutrophil-derived protein YKL-40 during storage of various blood components.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2001;50(2):107-11.
2000: Holten-Andersen M N; Stephens R W; Nielsen H J; Murphy G; Christensen I J; Stetler-Stevenson W; Brünner N
High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(11):4292-9.
2000: Mynster T; Christensen I J; Moesgaard F; Nielsen H J
Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group.
The British journal of surgery 2000;87(11):1553-62.
2000: Werther K; Christensen I J; Brünner N; Nielsen H J
Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2000;26(7):657-62.
2000: Nielsen H J; Christensen I J; Sørensen S; Moesgaard F; Brünner N
Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group.
Annals of surgical oncology 2000;7(8):617-23.
2000: Werther K; Normark M; Hansen B F; Brünner N; Nielsen H J
The use of the CELLection kit in the isolation of carcinoma cells from mononuclear cell suspensions.
Journal of immunological methods 2000;238(1-2):133-41.
2000: Mynster T; Nielsen H J
The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Danish RANX05 Colorectal Cancer Study Group.
Scandinavian journal of gastroenterology 2000;35(2):212-7.
2000: Høyer-Hansen G; Hamers M J; Pedersen A N; Nielsen H J; Brünner N; Danø K; Stephens R W
Loss of ELISA specificity due to biotinylation of monoclonal antibodies.
Journal of immunological methods 2000;235(1-2):91-9.
1999: Nielsen H J; Hansen U; Christensen I J; Reimert C M; Brünner N; Moesgaard F
Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue.
The Journal of pathology 1999;189(4):487-95.
1999: Nielsen H J; Werther K; Mynster T; Brünner N
Soluble vascular endothelial growth factor in various blood transfusion components.
Transfusion 1999;39(10):1078-83.
1999: Pedersen A N; Brünner N; Høyer-Hansen G; Hamer P; Jarosz D; Larsen B; Nielsen H J; Stephens R W
Determination of the complex between urokinase and its type-1 inhibitor in plasma from healthy donors and breast cancer patients.
Clinical chemistry 1999;45(8 Pt 1):1206-13.
1999: Mynster T; Dybkjaer E; Reimert C M; Pedersen A N; Ostergaard K; Vangsgaard K; Nielsen H J
Prestorage leukofiltration of whole blood and SAGM blood prevents extracellular bioactive substance accumulation.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1999;48(7):363-8.
1999: Mynster T; Hammer J H; Nielsen H J
Prestorage and bedside leucofiltration of whole blood modulates storage-time-dependent suppression of in vitro TNFalpha release.
British journal of haematology 1999;106(1):248-51.
1999: Hammer J H; Mynster T; Reimert C M; Pedersen A N; Nielsen H J
Reduction of bioactive substances in stored donor blood: prestorage versus bedside leucofiltration.
European journal of haematology 1999;63(1):29-34.
1999: Werther K; Normark M; Hansen B F; Nielsen H J
Immunoglobulin and enzyme-conjugated dextran polymers enhance u-PAR staining intensity of carcinoma cells in peripheral blood smears.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1999;47(7):959-64.
1999: Holten-Andersen M N; Murphy G; Nielsen H J; Pedersen A N; Christensen I J; Høyer-Hansen G; Brünner N; Stephens R W
Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.
British journal of cancer 1999;80(3-4):495-503.
1999: Stephens R W; Nielsen H J; Christensen I J; Thorlacius-Ussing O; Sørensen S; Danø K; Brünner N
Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis.
Journal of the National Cancer Institute 1999;91(10):869-74.
1999: Tonnesen H; Rosenberg J; Nielsen H J; Rasmussen V; Hauge C; Pedersen I K; Kehlet H
Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial.
BMJ (Clinical research ed.) 1999;318(7194):1311-6.
1999: Jensen C M; Pilegaard R; Hviid K; Nielsen J D; Nielsen H J
Quality of reinfused drainage blood after total knee arthroplasty.
The Journal of arthroplasty 1999;14(3):312-8.
1999: Nielsen H J; Hammer J H; Krarup A L; Nielsen L M; Reimert C M; Pedersen A N; Dybkjaer E; Partoft S; Alsbjørn B
Prestorage leukocyte filtration may reduce leukocyte-derived bioactive substance accumulation in patients operated for burn trauma.
Burns : journal of the International Society for Burn Injuries 1999;25(2):162-70.
1999: Cintin C; Johansen J S; Christensen I J; Price P A; Sørensen S; Nielsen H J
Serum YKL-40 and colorectal cancer.
British journal of cancer 1999;79(9-10):1494-9.
1999: Brünner N; Nielsen H J; Hamers M; Christensen I J; Thorlacius-Ussing O; Stephens R W
The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1999;107(1):160-7.
1998: Edvardsen L; Taaning E; Mynster T; Hvolris J; Drachman O; Nielsen H J
Bioactive substances in buffy-coat-derived platelet pools stored in platelet-additive solutions.
British journal of haematology 1998;103(2):445-8.
1998: Werther K; Brünner N A; Nielsen H J
[Can detection of cancer cells in bone marrow and peripheral blood be used in diagnosis and patient monitoring?]
Ugeskrift for laeger 1998;160(41):5923-6.
1998: Nielsen H J; Brünner N A; Thorlacius-Ussing O; Kehlet H
[New prognostic markers in colorectal cancer]
Ugeskrift for laeger 1998;160(32):4617-21.
1998: Volck B; Price P A; Johansen J S; Sørensen O; Benfield T L; Nielsen H J; Calafat J; Borregaard N
YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils.
Proceedings of the Association of American Physicians 1998;110(4):351-60.
1998: Kehlet H; Nielsen H J
Impact of laparoscopic surgery on stress responses, immunofunction, and risk of infectious complications.
New horizons (Baltimore, Md.) 1998;6(2 Suppl):S80-8.
1998: Petersen L J; Hansen U; Kristensen J K; Nielsen H; Skov P S; Nielsen H J
Studies on mast cells and histamine release in psoriasis: the effect of ranitidine.
Acta dermato-venereologica 1998;78(3):190-3.
1998: Nielsen H J; Pappot H; Christensen I J; Brünner N; Thorlacius-Ussing O; Moesgaard F; Danø K; Grøndahl-Hansen J
Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer.
BMJ (Clinical research ed.) 1998;316(7134):829-30.
1998: Moesgaard F; Jensen L S; Christiansen P M; Thorlacius-Ussing O; Nielsen K T; Rasmussen N R; Bardram L; Nielsen H J
The effect of ranitidine on postoperative infectious complications following emergency colorectal surgery: a randomized, placebo-controlled, double-blind trial.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1998;47(1):12-7.
1998: Mynster T; Dybkjoer E; Kronborg G; Nielsen H J
Immunomodulating effect of blood transfusion: is storage time important?
Vox sanguinis 1998;74(3):176-81.
1997: Hammer J H; Mynster T; Reimert C M; Pedersen A N; Dybkjaer E; Alsbjørn B; Nielsen H J
Effect of heating on extracellular bioactive substances in stored human blood: in vitro study.
The Journal of trauma 1997;43(5):799-803.
1997: Stephens R W; Pedersen A N; Nielsen H J; Hamers M J; Høyer-Hansen G; Rønne E; Dybkjaer E; Danø K; Brünner N
ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients.
Clinical chemistry 1997;43(10):1868-76.
1997: Jensen L S; Hokland M E; Nielsen H J
[Leukocyte filtration in elective colorectal surgery. Reduced transfusion associated immunosuppression after bedside procedures]
Ugeskrift for laeger 1997;159(34):5093-7.
1997: Nielsen H J; Reimert C; Pedersen A N; Dybkjoer E; Brünner N; Alsbjørn B; Skov P S
Leucocyte-derived bioactive substances in fresh frozen plasma.
British journal of anaesthesia 1997;78(5):548-52.
1997: Nielsen H J; Skov F; Dybkjaer E; Reimert C M; Pedersen A N; Brünner N; Skov P S
Leucocyte and platelet-derived bioactive substances in stored blood: effect of prestorage leucocyte filtration.
European journal of haematology 1997;58(4):273-8.
1997: Nielsen H J; Reimert C M; Dybkjaer E; Roed J; Alsbjørn B
Bioactive substance accumulation and septic complications in a burn trauma patient: effect of perioperative blood transfusion?
Burns : journal of the International Society for Burn Injuries 1997;23(1):59-63.
1997: Nielsen H J; Kristensen J K; Hansen U; Nielsen H I; Skov P S; Petersen L M
[Clinical effect of ranitidine in psoriasis. An open prospective study]
Ugeskrift for laeger 1997;159(5):598-600.
1996: Nielsen H J; Reimert C M; Pedersen A N; Brünner N; Edvardsen L; Dybkjaer E; Kehlet H; Skov P S
Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood.
Transfusion 1996;36(11-12):960-5.
1996: Nielsen H J
Histamine-2 receptor antagonists as immunomodulators: new therapeutic views?
Annals of medicine 1996;28(2):107-13.
1996: Nielsen H J; Edvardsen L; Vangsgaard K; Dybkjaer E; Skov P S
Time-dependent histamine release from stored human blood products.
The British journal of surgery 1996;83(2):259-62.
1995: Jurlander J; de Nully Brown P; Skov P S; Henrichsen J; Heron I; Obel N; Mortensen B T; Hansen M M; Geisler C H; Nielsen H J
Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(11):1902-9.
1995: Nielsen H J; Moesgaard F; Hammer J H
Effect of ranitidine and low-dose interleukin-2 in vitro on NK-cell activity in peripheral blood from patients with liver metastases from colorectal cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(5):526-30.
1995: Nielsen H J; Nielsen H I; Jensen S; Moesgaard F A
[The effect of ranitidine on postoperative monocyte and neutrophil granulocyte function]
Ugeskrift for laeger 1995;157(44):6119-24.
1995: Nielsen H J
Detrimental effects of perioperative blood transfusion.
The British journal of surgery 1995;82(5):582-7.
1995: Nielsen H J
The effect of histamine type-2 receptor antagonists on posttraumatic immune competence.
Danish medical bulletin 1995;42(2):162-74.
1995: Nielsen H J; Petersen L J; Skov P S
Human, recombinant interleukin-2 induces in vitro histamine release in a dose-dependent manner.
Cancer biotherapy 1995;10(4):279-86.
1994: Nielsen H J; Mynster T; Jensen S; Hammer J; Nielsen H
Effect of ranitidine on soluble interleukin 2 receptors and CD8 molecules in surgical patients.
The British journal of surgery 1994;81(12):1747-51.
1994: Nielsen H J; Nielsen H; Jensen S; Moesgaard F
Ranitidine improves postoperative monocyte and neutrophil function.
Archives of surgery (Chicago, Ill. : 1960) 1994;129(3):309-15.
1994: Rønne E; Behrendt N; Ploug M; Nielsen H J; Wöllisch E; Weidle U; Danø K; Høyer-Hansen G
Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay.
Journal of immunological methods 1994;167(1-2):91-101.
1994: Tønnesen H; Petersen K R; Højgaard L; Stokholm K H; Nielsen H J; Knigge U P; Kehlet H
[Postoperative morbidity among alcohol abusers]
Ugeskrift for laeger 1994;156(3):287-90.
1992: Nielsen H J; Hammer J H
Possible role of histamine in pathogenesis of autoimmune diseases: implications for immunotherapy with histamine-2 receptor antagonists.
Medical hypotheses 1992;39(4):349-55.
1992: Tønnesen H; Petersen K R; Højgaard L; Stokholm K H; Nielsen H J; Knigge U; Kehlet H
Postoperative morbidity among symptom-free alcohol misusers.
Lancet 1992;340(8815):334-7.
1992: Nielsen H J; Hammer J H; Moesgaard F; Heron I; Kehlet H
Ranitidine improves postoperative suppression of antibody response to preoperative vaccination.
Surgery 1992;111(1):69-73.
1992: Hammer J H; Nielsen H J; Moesgaard F; Kehlet H
Duration of postoperative immunosuppression assessed by repeated delayed type hypersensitivity skin tests.
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 1992;24(3):133-7.
1991: Nielsen H J
Histamine and histamine type-2 receptor antagonists in psoriasis. Mechanisms and speculations.
Danish medical bulletin 1991;38(6):478-80.
1991: Nielsen H J; Hammer J H; Moesgaard F; Kehlet H
Possible role of histamine-2 receptor antagonists for adjuvant treatment in colorectal cancer. Clinical review.
The European journal of surgery = Acta chirurgica 1991;157(8):437-41.
1991: Nielsen H J; Hammer J H; Moesgaard F; Kehlet H
Comparison of the effects of SAG-M and whole-blood transfusions on postoperative suppression of delayed hypersensitivity.
Canadian journal of surgery. Journal canadien de chirurgie 1991;34(2):146-50.
1990: Nielsen H J; Nielsen H; Moesgaard F; Tvede N; Klarlund K; Mansa B; Drivsholm A
The effect of ranitidine on cellular immunity in patients with multiple myeloma.
Cancer immunology, immunotherapy : CII 1990;32(3):201-5.
1989: Nielsen H J; Witt K; Moesgaard F; Kehlet H
Ranitidine for improvement of delayed hypersensitivity response in patients with sepsis.
Acta chirurgica Scandinavica 1989;155(9):445-9.
1989: Nielsen H J; Hammer J H; Moesgaard F; Kehlet H
[Immunologic consequences of surgery, anesthesia and blood transfusion. Surgical immunosuppression]
Ugeskrift for laeger 1989;151(37):2348-52.
1989: Nielsen H J; Pedersen B K; Moesgaard F; Haahr P M; Kehlet H
Effect of ranitidine on postoperative suppression of natural killer cell activity and delayed hypersensitivity.
Acta chirurgica Scandinavica 1989;155(8):377-82.
1989: Nielsen H J; Hammer J H; Moesgaard F; Kehlet H
Ranitidine prevents postoperative transfusion-induced depression of delayed hypersensitivity.
Surgery 1989;105(6):711-7.
1989: Nielsen H J; Moesgaard F; Kehlet H
Ranitidine for prevention of postoperative suppression of delayed hypersensitivity.
American journal of surgery 1989;157(3):291-4.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hans Jørgen Nielsen

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hans Jørgen Nielsen (preview)

All Publications